Skip to main content

Table 1 Baseline characteristics of the participants according to the insulin stratification

From: Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study

 

I(≤6.01)

(n = 592)

II (6.02-7.29)

(n = 585)

III(7.30-8.97)

(n = 588)

IV(≥8.98)

(n = 585)

p-value

Age(yr)

Male %

41.9 ± 6.3

75.5

42.0 ± 6.4

74.2

40.7 ± 6.2

73.8

40.7 ± 6.0

74.2

< 0.001

0.915

Life style

     

   Alcohol consumption (g/day)

12.6 ± 14.8

12.4 ± 16.9

11.3 ± 15.5

11.8 ± 14.8

0.206

   Smoking % (No/Ex/Current)

47.1/18.6/34.3

51.3/20.3/28.4

49.0/23/28.1

42.6/26.8/30.6

0.003

Exercise %

(none/less than once per week/more than once per week)

21.6/31.6/46.8

22.9/33.5/43.6

24.1/39.6/36.2

25/42.7/32.3

< 0.001

BMI(kg/m2)

22.7 ± 2.4

23.1 ± 2.5

23.8 ± 2.5

24.8 ± 2.8

0.018

Waist circumference (cm)

78.4 ± 8.2

79.1 ± 8.1

80.9 ± 8.1

83.7 ± 8.8

< 0.001

Systolic BP (mmHg)

112.9 ± 12.6

113.4 ± 12.4

114.5 ± 13.8

115.6 ± 13.6

< 0.001

Diastolic BP mmHg)

73.2 ± 9.6

73.4 ± 9.6

73.8 ± 10.1

74.5 ± 10.1

0.022

Fasting glucose (mg/dl)

87.4 ± 8.0

89.0 ± 7.9

90.9 ± 8.1

91.6 ± 7.6

< 0.001

Triglyceride (mg/dl)

112.4 ± 61.2

121.0 ± 64.3

135.2 ± 70.3

154.2 ± 82.6

< 0.001

HDL-cholesterol(mg/dl)

58.7 ± 11.8

58.2 ± 11.6

56.8 ± 11.6

55.3 ± 11.2

< 0.001

LDL-cholesterol(mg/dl)

117.2 ± 30.0

118.6 ± 30.0

119.6 ± 29.4

124.3 ± 31.0

< 0.001

hs-CRP(mg/L)

0.82 ± 1.16

0.78 ± 1.18

0.92 ± 1.46

1.15 ± 1.87

0.04

  1. Values expressed as n (%) or mean ± standard deviation (by Student t -test)
  2. BMI, body mass index; BP, blood pressure; hs-CRP, high-sensitivity C-reactive protein; MS, metabolic syndrome; DM, diabetes mellitus